TrialCancer reports (Hoboken, N.J.)2025

Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer.

Seema Nagpal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.